DE000PE98CP3/ DE000PE98CP3 /
11/8/2024 9:20:37 PM | Chg.-0.110 | Bid9:52:34 PM | Ask9:52:34 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.690EUR | -6.11% | 1.700 Bid Size: 4,600 |
1.730 Ask Size: 4,600 |
ACS ACTIVIDADES CONS... | 26.2516 - | 12/31/2078 | Call |
Newsfile Corp
10/1
Avraham Plastic Surgery NYC Announces Natural Reconstruction for Mastectomy Patients Using Microsurg...
Newsfile Corp
9/6
Air & Energy of NWFL Introduces Comprehensive Energy Efficiency Audits, Enhancing Pensacola Air Cond...
GlobeNewswire
8/27
Parsons Selected as Lead Engineer to Add Express Toll Lanes to State Route 400 in Georgia
GlobeNewswire
8/22
Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Me...
GlobeNewswire
8/22
Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacim...
GlobeNewswire
8/21
ProLynx announces preclinical results of long-acting semaglutide requiring once monthly dosing
Newsfile Corp
8/15
Droplet Lab Launches Innovative Instrument Set to Elevate Chemistry and Material Science Education
GlobeNewswire
8/15
NobleAI to Present at American Chemical Society’s Fall Conference, “Elevating Chemistry”
GlobeNewswire
8/6
Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug
GlobeNewswire
8/6
SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article...
GlobeNewswire
8/2
FDA has accepted a BLA for bentracimab, the first and only ticagrelor reversal agent, for filing and...
GlobeNewswire
7/30
Award-Winning Material Inventor Joins as Advisor for AI Innovator of Climate Technologies
GlobeNewswire
7/30
NewHydrogen CEO Steve Hill Explores AI’s Role in Cutting-Edge Hydrogen Solutions with Renowned Compu...
GlobeNewswire
7/3
NH TherAguix Announces Publication of Groundbreaking Study on AGuIX® Nanoparticles Enhancing Cervica...
GlobeNewswire
7/3
Advantest to Showcase Latest Test Technology at SEMICON West 2024, July 9-11, in San Francisco
GlobeNewswire
7/2
Ipsen expands collaboration and license agreement for development of Cabometyx® in advanced neuroend...
GlobeNewswire
6/25
Sustainable Mom and Baby Brands Commit to Tackling Global Plastic Pollution with rePurpose Global